Trademark Details For RISARG (Serial Number 79189840)

  •  Home
  •  Print
RISARG
5
36
15
0
Basic Information
Serial Number  United States - USPTO 79189840
Registration Number 5098032
Mark
RISARG
Filing Date Jun-30-2016
Status
Dead  
CANCELLED – .. (709)
CANCELLED – SECTION 71
Attorney Name
TTAB
0
Action Tags
  


  • NOVARTIS


005Pharmaceuticals

U.S Class(es): 006, 018, 044, 046, 051, 052





Correspondences

NameNovartis Pharma AG, Trademark Department
AddressPostfach CH-4002 Basel, SWITZERLAND

Prosecution History

  
USPTO 
DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Aug-04-2016SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB   SDRCM
Aug-05-2016LIMITATION FROM ORIGINAL APPLICATION ENTERED   LIMII
Aug-08-2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED   NWOSI
Aug-09-2016ASSIGNED TO EXAMINER   DOCKD
Aug-12-2016APPLICATION FILING RECEIPT MAILED   MAFRO
Aug-15-2016APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAO
Sep-07-2016NOTICE OF PUBLICATION   NPUBO
Sep-07-2016NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB   OP2RP
Sep-07-2016NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB   OPNSP
Sep-27-2016PUBLISHED FOR OPPOSITION   PUBOA
Dec-13-2016REGISTERED-PRINCIPAL REGISTER   R.PRA
Jan-12-2017GRANT OF PROTECTION CREATED, TO BE SENT TO IB   GPARP
Feb-15-2017FINAL DISPOSITION PROCESSED   FIMPP
Feb-15-2017FINAL DISPOSITION NOTICE SENT TO IB   FICSP
Jun-30-2017NOTIFICATION PROCESSED BY IB   GPNXP
Oct-27-2017NOTIFICATION PROCESSED BY IB   GPNXP
Jun-30-2023CANCELLED SECTION 71   C71TO
Feb-29-2024TOTAL INVALIDATION OF REG EXT PROTECTION CREATED   INTRP
Apr-11-2025GENERIC MADRID TRANSACTION CREATED   XXCRP
Apr-11-2025INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE   INNAR
Apr-11-2025GENERIC MADRID TRANSACTION SENT TO IB   XXSSO
May-31-2025Further Decision Processed by IB